Erlotinib (Tarceva) in patients with advanced non-small lung cancer (NSCLC)-The single institution experience

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	TOMÍŠKOVÁ Marcela SKŘIČKOVÁ Jana VAŠUTOVÁ Irena
Year of publication	2008
Type	Article in Periodical
Magazine / Source	Journal of Thoracic Oncology
MU Faculty or unit	Faculty of Medicine
Citation
Field	Pneumology
Keywords	non-small cell lung cancer; advanced cancer; treatmetment; erlotinib
Description	A single-instution experience is presented of Erlotinib (Tarceva) used to treat patients with advanced non-small lung cancer (NSCLC).
Related projects:	Environment - carcinogenesis - oncology